1. Home
  2. OCGN vs IONR Comparison

OCGN vs IONR Comparison

Compare OCGN & IONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • IONR
  • Stock Information
  • Founded
  • OCGN 2013
  • IONR 2001
  • Country
  • OCGN United States
  • IONR Australia
  • Employees
  • OCGN N/A
  • IONR N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • IONR
  • Sector
  • OCGN Health Care
  • IONR
  • Exchange
  • OCGN Nasdaq
  • IONR Nasdaq
  • Market Cap
  • OCGN 338.2M
  • IONR 397.5M
  • IPO Year
  • OCGN N/A
  • IONR N/A
  • Fundamental
  • Price
  • OCGN $0.99
  • IONR $5.74
  • Analyst Decision
  • OCGN Strong Buy
  • IONR
  • Analyst Count
  • OCGN 3
  • IONR 0
  • Target Price
  • OCGN $5.33
  • IONR N/A
  • AVG Volume (30 Days)
  • OCGN 3.5M
  • IONR 62.0K
  • Earning Date
  • OCGN 11-08-2024
  • IONR 01-01-0001
  • Dividend Yield
  • OCGN N/A
  • IONR N/A
  • EPS Growth
  • OCGN N/A
  • IONR N/A
  • EPS
  • OCGN N/A
  • IONR N/A
  • Revenue
  • OCGN $7,263,000.00
  • IONR N/A
  • Revenue This Year
  • OCGN N/A
  • IONR N/A
  • Revenue Next Year
  • OCGN N/A
  • IONR N/A
  • P/E Ratio
  • OCGN N/A
  • IONR N/A
  • Revenue Growth
  • OCGN 112.62
  • IONR N/A
  • 52 Week Low
  • OCGN $0.35
  • IONR $2.90
  • 52 Week High
  • OCGN $2.11
  • IONR $9.35
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 50.03
  • IONR 38.44
  • Support Level
  • OCGN $0.91
  • IONR $5.66
  • Resistance Level
  • OCGN $0.98
  • IONR $7.21
  • Average True Range (ATR)
  • OCGN 0.07
  • IONR 0.67
  • MACD
  • OCGN 0.02
  • IONR -0.33
  • Stochastic Oscillator
  • OCGN 40.08
  • IONR 2.17

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About IONR ioneer Ltd

Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S.-based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.

Share on Social Networks: